Hwail Pharmaceutical Co.,Ltd. (061250.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩5,750 (-1.20%) as of
Key statistics
- Market cap
- 48.38B
- Dividend yield
- 0.00%
- 52-week range
- 5,660.00 – 12,500.00
- Beta
- 0.17
- Revenue (TTM)
- 107.87B
- Profit margin
- 1.78%
- Volume
- 4.69k
About Hwail Pharmaceutical Co.,Ltd.
Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seongnam-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.